Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Cardiovasc Intervent Radiol. 2012 Jun 22;36(2):449–459. doi: 10.1007/s00270-012-0424-y

Table 5.

Efficacy: tumor response by imaging

Features Baseline: before DEB-TACE) (n = 32 lesions in 13 patients) 1 month after initial DEB-TACE (n = 32 lesions in 13 patients) 6 months after initial DEB-TACE (n = 26 lesions in 10 patients) 12 months after initial DEB-TACE (n = 19 lesions in 6 patients)
Tumor size ± SD (cm) 4.5 ± 2.5 4.1 ± 2.7 3.1 ± 2.6 3.4 ± 3
% change −12 −30 −40
p p = 0.0003 p < 0.0001 p < 0.0001
Tumor enhancement ± SD (%) 88 ± 21.8 37 ± 22 40 ± 35 33 ± 33
% change −56 −58 −65
p p < 0.0001 p < 0.0001 p < 0.0001